This announcement is a separate document:
江苏康缘药业股份有限公司关于以集中竞价交易方式回购公司股份比例达2%暨回购进展的公告
Announcement of Jiangsu Kangyuan Pharmaceutical Co., Ltd. on the repurchase ratio of the company\'s shares reached 2% through centralized bidding transactions and the progress of the repurchase
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.